Bridgewater Surgeries is one of over 600 practices in England contributing pseudonymised data for national research and surveillance.
These data enable continuous monitoring of infections and diseases in the community and is used in ethically approved research. The RCGP RSC is the main source of information for Public Health England (PHE) and helps with prediction and management of flu outbreaks and pandemics.
Providing pseudonymised data does not affect patients, their care or privacy, however if you no longer wish to allow your information to be used, please speak to your GP.
Current Studies at Bridgewater Surgeries
1. East London Genes and Health - Cardiovascular disease study
Hypothesis: How does genetics (DNA) link to Cardiovascular disease?
South Asian people have some of the highest rates of heart disease, diabetes, and poor health in the UK. Living with a long term illness has a major impact on a persnon's quality of life and on their family.
East London Genes and Health is medical research study set up to help fight against these and other major disease.
The primary objective of the research is to investigate and understand why some individuals have a disease, and help suggest how new medicines and treatments might be develeped.
Aspirin To Target Arterial Chronic Kidney Disease
Hypothesis: Can 75mg aspirin (OD) to usual care reduce risk of major vascular events in patients with CKD?
In patients with cardiovascular disease (CVD), there is good evidence that antiplatelet therapy reduces the risk of subsequent vascular events (secondary prevention), and that overall these benefits outweigh the risks of major bleeding, which is the principle complication of therapy.
There is currently insufficient evidence to recommend the use of aspirin for the primary prevention of CVD in CKD.
The primary objective of the research is to test the hypothesis that low-dose (75mg non-enteric coated) aspirin reduces the risk of major vascular events (excluding confirmed intracranial haemorrhage) (primary endpoint) in people with CKD who do not have pre-existing CVD.
3. PAM Study (Programme on Adherence to Medication ) Hypertension Study
Hypothesis: Assess the feasibility of face to face and digital intervention to support adherence to High Blood Pressure medicaion = Improve BP
In England, there are 13.5 million adults diagnosed with Hypertension and more than 5.5 million are undiagnosed. Hypertension (High Blood Pressure; HBP) accounts for 75,000 deaths, and is often accompanied with diabetes type 2 (DT2), cholesterol, and other health problems.
The primary objective of the research is to assess the feasibility of face to face and digital intervention to support adherence to anti-hypertensive medications and improve blood pressure in primary care.
Hypertension is a major risk factor for disability and premature deaths, and medication adherence can considerably lower these risks.
CLinical Informatics for Mind and Brain Health
Hypothesis:To establish patient and public views on the sharing of NHS identified health data (for clinical purposes) and de-identified health data (for research) across the UK by means of a national survey
5. MoodBuster study
Are you experiencing increased anxiety or low mood due to COVID-19 or were already experiencing these symptoms and would like to be part of research?
What? We want to test MoodBuster, a guide website and app that uses the principles of CBT (Cognitive Behavioural Therapy) for self-management of low mood. You will take part in the study in your own time from the comfort of your home.
- Aged 18 or older
- Have signs of low mood
- Have both a computer and smartphone (Android or iPhone)
- and have never been diagnosed with depression
Where and when?
Contact us for more information:
Previous studies – No active recruitment
- ACCESS study
- ARRISA UK
- Lifestyle Health and Wellbeing
Are you interested in one of the research studies?
That's great! The first step is to let us know and we will contact you and provide more information:
- Send us an email on email@example.com with a title: 'Research study', or
- Phone the main reception (01923 202600) and ask to speak to our Research Team, Rezwona Choudhury and Dr Ariff Amin